Morgan Stanley Ups Cephalon to Overweight from Equal-Weight

The company on Thursday announced the settlement of a patent infringement dispute

Morgan Stanley upgraded Cephalon (CEPH ) to overweight from equal-weight, after the company on Thursday announced the settlement of a patent infringement dispute with Ranbaxy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.